We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
05 Mar 2022 - 09 Mar 2022
Virtual Venue

Bacterium and Viral Coinfection Contributes to Postinfectious Hydrocephalus

By LabMedica International staff writers
Posted on 12 Oct 2020
Print article
Image: Yellow color shows thiamine degradation on an agar plate of cultured Paenibacillus thiaminolyticus (Photo courtesy of Catherine A. Richter, PhD).
Image: Yellow color shows thiamine degradation on an agar plate of cultured Paenibacillus thiaminolyticus (Photo courtesy of Catherine A. Richter, PhD).
Neonatal sepsis often precedes postinfectious hydrocephalus (PIH), although the manifestations of hydrocephalus typically emerge in the months after the neonatal period as sufficient cerebrospinal fluid (CSF) accumulates such that cranial expansion garners medical attention.

Postinfectious hydrocephalus (PIH), is the most common cause of pediatric hydrocephalus worldwide, yet the microbial pathogens underlying this disease remain to be elucidated. Of the estimated 400,000 new cases each year, about half are estimated to be postinfectious, with the largest number of cases in low- and middle-income countries, especially sub-Saharan Africa.

A team of international scientists collaborating with the Columbia University's Mailman School of Public Health (New York, NY, USA) analyzed samples from 100 patients, 64 with post-infectious hydrocephalus (PIH) and 36 with non-post-infectious hydrocephalus (NPIH), all of whom were less than three months old who were seen at the CURE Children's Hospital of Uganda (Mbale, Uganda)

Blood was sampled with aseptic technique at the time of surgery, either at the time of catheter placement for an intravenous line or during venipuncture for routine laboratory testing. Cerebrospinal fluid (CSF) was obtained at the time of initial surgery. The team used both Sanger-based sequencing of bacterial 16S ribosomal DNA V1-V4 regions and next-generation sequencing of the V1-V2 and V4 regions. A broad screen for viral presence was performed in two different ways: VirCapSeq oligomer concentration and total RNA sequencing analysis. For the viruses that appeared abundant in either PIH or NPIH, polymerase chain reaction (PCR) confirmation was performed.

Using a targeted viral detection capture approach called VirCapSeqVERT, the investigators uncovered 11 viral strains across slightly more than a third of CSF samples. Cytomegalovirus was found among a portion of post-infectious hydrocephalus patients' CSF samples, but not among non-post-infectious hydrocephalus patients. Cytomegalovirus is a common virus that typically causes minor symptoms in adults but may lead to neurological damage in infants who acquire it early in life. The team grew three Paenibacillus isolates in culture and used whole-genome sequencing analysis to identify them as P. thiaminolyticus. V1-V4 Sanger sequencing of subcloned amplicons identified Paenibacillus as a predominant organism within the PIH cohort (23 of 64), but not within the NPIH cohort (0 of 36). A hybrid method was used to reconstruct the genome of a P. thiaminolyticus isolate, combining short-read sequencing, optical mapping (Bionano Genomics, San Diego, CA, USA), and nanopore long contiguous sequencing (MinION, Oxford Nanopore Technologies, Oxford, UK).

The authors concluded that their findings showed that an unbiased pan-microbial approach enabled characterization of Paenibacillus in CSF samples from PIH cases, and point toward a pathway of more optimal treatment and prevention for PIH and other proximate neonatal infections.

Edith Mbabazi-Kabachelor, MD, MPH, director of research at CURE Children's Hospital of Uganda and a co-author of the study, said, “Hydrocephalus is the most common childhood neurosurgical condition that we see in the population that we serve. If hydrocephalus is left untreated in children less than two years old, the progressive increase in head size will lead to further brain damage, resulting in the majority of these children dying, and those that survive being left with severe cognitive and physical disability.” The study was published on September 30, 2020 in the journal Science Translational Medicine.

Related Links:
Columbia University's Mailman School of Public Health
CURE Children's Hospital of Uganda
Bionano Genomics
Oxford Nanopore Technologies


Gold Supplier
COVID-19 Real Time RT-PCR Kit
respiraScreen 1
New
Multi-Tube Vortexer
BenchMixer XL
New
Electrolyte Analyzer
CARELYTE-500 Series
New
UV/Vis Spectrophotometer
BioDrop DUO+

Print article
IIR Middle East

Channels

Molecular Diagnostics

view channel
Image: The ultrarapid genome sequencing pipeline, indicating all processes from sample collection to a diagnosis. Vertically stacked processes are run in parallel (Photo courtesy of Stanford University)

Ultrarapid Nanopore Genome Sequencing in a Critical Care Setting

A genetic diagnosis can guide clinical management and improve prognosis in critically ill patients, and much effort has gone into developing methods that result in rapid, reliable results.... Read more

Hematology

view channel
Image: My Qualiris QC (Photo courtesy of Stago)

Stago Launches New My Qualiris QC Website for Brand-New User Experience

Stago (Paris, France) has launched its new My Qualiris QC website which provides a brand-new user experience with a 24/7 accessible web-application where the results of a user’s network are only a few clicks away.... Read more

Industry

view channel
Illustration

Global Immunofluorescence Assay (IFA) Market to Surpass USD 4 Billion by 2028 Due to Growing Burden of Infectious Diseases

The global immunofluorescence assay (IFA) market is expected to reach USD 4.01 billion by 2028, driven by the increasing global healthcare burden of chronic and infectious diseases, rising application... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.